Minuteful Kidney for home testing of albumin-to-creatine ratio (ACR)

Record ID 32018002478
Authors' objectives: To examine the evidence on using closed loop systems and the artificial pancreas for the management of type 1 diabetes. We were asked to consider the cost-effectiveness of these technologies compared with current diabetes management options, and to consider clinical effectiveness, safety and patient aspects.
Authors' results and conclusions: Minuteful Kidney has the potential to save costs for the NHS but only if the abnormal tests are properly followed up and people go on to have the necessary further tests and treatments.
Authors' recomendations: More trials are needed that test closed loop systems in larger groups of people, over a longer time period, and in a wider variety of participants (for example people with poor glucose control). Trials assessing the artificial pancreas are also required. Trials that collect data to support value for money assessment in the UK would be very beneficial.
Project Status: Completed
Year Published: 2022
Requestor: Healthy.io
English language abstract: An English language summary is available
Publication Type: Other
Country: Scotland, United Kingdom
MeSH Terms
  • Diabetes Mellitus
  • Hypertension
  • Smartphone
  • Biomarkers
  • Creatinine
  • Albuminuria
  • Kidney Failure, Chronic
  • Urinalysis
  • Self-Testing
  • Minuteful Kidney ACR
Organisation Name: Scottish Health Technologies Group
Contact Address: Scottish Health Technologies Group, Delta House, 50 West Nile Street, Glasgow, G1 2NP Tel: 0141 225 6998
Contact Name: his.shtg@nhs.scot
Contact Email: his.shtg@nhs.scot
Copyright: Scottish Health Technologies Group
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.